Evaluation of subcutaneously-implanted glucose sensors for continuous glucose measurements in hyperglycemic pigs
- PMID: 16634519
Evaluation of subcutaneously-implanted glucose sensors for continuous glucose measurements in hyperglycemic pigs
Abstract
Background: Subcutaneously-implanted glucose sensors for continuous glucose monitoring have the potential to replace serial blood glucose measurements. The objective of the present study was to test whether continuous glucose measurements could be obtained with glucose sensors implanted in the subcutis of pigs. Moreover, the in vivo biocompatibility of the sensors was evaluated since an inflammatory reaction may lead to drift in sensor-signaling.
Materials and methods: Two types of glucose sensor were implanted for 3 days in the subcutis of hyperglycemic pigs. The plasma glucose concentration was correlated to the sensor outputs, and tissue was sampled for histological evaluation.
Results: There was a good correlation between the interstitial fluid and blood glucose levels. However, there was a statistical significantly difference in linearity from days 0 and 1 to day 2 (p<0.001) and variations in the sensitivity and background current of individual sensors were observed over time. The tissue reaction caused by the sensors was a mild focal subacute fibrinous dermatitis.
Conclusion: Continuous glucose measurement can be achieved by glucose sensors implanted in the subcutis of pigs. The observed drift in sensor signals over time may have been caused by heterophils, macrophages and/or fibrinogen at the tissue-sensor interface.
Similar articles
-
Continuous glucose monitoring in interstitial fluid using glucose oxidase-based sensor compared to established blood glucose measurement in rats.Anal Chim Acta. 2007 Jan 2;581(1):7-12. doi: 10.1016/j.aca.2006.08.016. Epub 2006 Aug 18. Anal Chim Acta. 2007. PMID: 17386418
-
[Subcutaneously implantable glucose sensors in patients with diabetes mellitus; still many problems].Ned Tijdschr Geneeskd. 2002 Jul 13;146(28):1313-6. Ned Tijdschr Geneeskd. 2002. PMID: 12148218 Review. Dutch.
-
Enzymatic glucose sensors. Improved long-term performance in vitro and in vivo.ASAIO J. 1994 Apr-Jun;40(2):157-63. ASAIO J. 1994. PMID: 8003752
-
Biocompatibility of an enzyme-based, electrochemical glucose sensor for short-term implantation in the subcutis.Diabetes Technol Ther. 2006 Oct;8(5):546-59. doi: 10.1089/dia.2006.8.546. Diabetes Technol Ther. 2006. PMID: 17037969
-
Biosensors for real-time in vivo measurements.Biosens Bioelectron. 2005 Jun 15;20(12):2388-403. doi: 10.1016/j.bios.2004.12.003. Epub 2005 Jan 15. Biosens Bioelectron. 2005. PMID: 15854814 Review.
Cited by
-
Clinical evaluation of a transcutaneous interrogated fluorescence lifetime-based microsensor for continuous glucose reading.J Diabetes Sci Technol. 2009 Jan;3(1):98-109. doi: 10.1177/193229680900300111. J Diabetes Sci Technol. 2009. PMID: 20046654 Free PMC article. Clinical Trial.
-
Recent advances in continuous glucose monitoring: biocompatibility of glucose sensors for implantation in subcutis.J Diabetes Sci Technol. 2007 Sep;1(5):746-52. doi: 10.1177/193229680700100520. J Diabetes Sci Technol. 2007. PMID: 19885143 Free PMC article.
-
Lymph Nodes Draining Infections Investigated by PET and Immunohistochemistry in a Juvenile Porcine Model.Molecules. 2022 Apr 27;27(9):2792. doi: 10.3390/molecules27092792. Molecules. 2022. PMID: 35566137 Free PMC article.
-
Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays.Diabetes. 2019 Oct;68(10):1892-1901. doi: 10.2337/db19-0229. Epub 2019 Aug 9. Diabetes. 2019. PMID: 31399432 Free PMC article.
-
Impact of Bindarit, a CCL2 Chemokine Synthesis Inhibitor, on Macrophage-Based Biofouling and Continuous Glucose Monitoring in vivo.Biosens Bioelectron X. 2024 Aug;19:100511. doi: 10.1016/j.biosx.2024.100511. Epub 2024 Jun 21. Biosens Bioelectron X. 2024. PMID: 39703931 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical